DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Tanezumab is an investigational drug.
There have been 17 clinical trials for Tanezumab. The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2016.
The most common disease conditions in clinical trials are Osteoarthritis, Osteoarthritis, Knee, and Low Back Pain. The leading clinical trial sponsors are Pfizer, Eli Lilly and Company, and Massachusetts General Hospital.
Recent Clinical Trials for Tanezumab
|Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis||Pfizer||Phase 2|
|Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis||Massachusetts General Hospital||Phase 2|
|Protocol to Monitor the Neurological Development of Infants With Exposure in Utero From Birth to 15 Months in Tanezumab Clinical Studies||Eli Lilly and Company||Phase 3|